[Therapeutic cytapheresis in hairy cell leukemia and chronic myelocytic leukemia]

Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis.

ESMO open·2022

Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinib.

ESMO open·2021

A validation study of combined resection and ablation therapy for multiple hepatocellular carcinoma.

Clinical radiology·2021

Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinoma.

ESMO open·2021

Differences in background characteristics of patients with chronic hepatitis C who achieved sustained virologic response with interferon-free versus interferon-based therapy and the risk of developing hepatocellular carcinoma after eradication of hepatitis C virus in Japan.

Journal of viral hepatitis·2016

Prophylactic fresh frozen plasma may prevent development of hepatic VOD after stem cell transplantation via ADAMTS13-mediated restoration of von Willebrand factor plasma levels.

Bone marrow transplantation·2007

[Treatment landscape of mature NK/T-cell lymphomas: treatment outcomes in Japan and future prospects].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Prophylactic or pre-emptive therapy with azacitidine or FLT3 inhibitor after allogeneic hematopoietic stem cell transplantation for AML and MDS].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Prophylactic use of tyrosine kinase inhibitors after allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Development of universal off-the-shelf T cell therapies derived from ES/iPS cells for leukemia and COVID-19].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Predictors of treatment-free remission (TFR) and second TFR attempts in chronic myeloid leukemia].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Complement-coagulation crosstalk in immunothrombosis].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

Rescue OTSC: salvage treatment for recurrent diverticular bleeding after failed conventional endoscopic hemostasis.

Revista espanola de enfermedades digestivas·2026

Pattern of Blood Donor Deferral in a Blood Establishment in Lagos.

Nigerian journal of clinical practice·2026

Balancing the "Faucet" and the "Drain": A Dual-Target Pharmacological Perspective on Fluid Dynamics in High-Altitude Cerebral Edema.

Current vascular pharmacology·2026

Post Atrial Septal Defect Device Closure Acute Severe Haemolysis: one hole closed, one valve leaked-A Rare Case Report.

Cardiology in the young·2026

Brazilian Society of Surgical Oncology Guideline for Bloodless Surgery (Part 3: Postoperative Strategies).

Journal of surgical oncology·2026

Current standards and novel concepts in thrombotic thrombocytopenic purpura.

Frontiers in medicine·2026

Related Experiment Videos

[Therapeutic cytapheresis in hairy cell leukemia and chronic myelocytic leukemia]

Related Concept Videos

Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis.

Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinib.

A validation study of combined resection and ablation therapy for multiple hepatocellular carcinoma.

Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinoma.

Differences in background characteristics of patients with chronic hepatitis C who achieved sustained virologic response with interferon-free versus interferon-based therapy and the risk of developing hepatocellular carcinoma after eradication of hepatitis C virus in Japan.

Prophylactic fresh frozen plasma may prevent development of hepatic VOD after stem cell transplantation via ADAMTS13-mediated restoration of von Willebrand factor plasma levels.

[Treatment landscape of mature NK/T-cell lymphomas: treatment outcomes in Japan and future prospects].

[Prophylactic or pre-emptive therapy with azacitidine or FLT3 inhibitor after allogeneic hematopoietic stem cell transplantation for AML and MDS].

[Prophylactic use of tyrosine kinase inhibitors after allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia].

[Development of universal off-the-shelf T cell therapies derived from ES/iPS cells for leukemia and COVID-19].

[Predictors of treatment-free remission (TFR) and second TFR attempts in chronic myeloid leukemia].

[Complement-coagulation crosstalk in immunothrombosis].

Rescue OTSC: salvage treatment for recurrent diverticular bleeding after failed conventional endoscopic hemostasis.

Pattern of Blood Donor Deferral in a Blood Establishment in Lagos.

Balancing the "Faucet" and the "Drain": A Dual-Target Pharmacological Perspective on Fluid Dynamics in High-Altitude Cerebral Edema.

Post Atrial Septal Defect Device Closure Acute Severe Haemolysis: one hole closed, one valve leaked-A Rare Case Report.

Brazilian Society of Surgical Oncology Guideline for Bloodless Surgery (Part 3: Postoperative Strategies).

Current standards and novel concepts in thrombotic thrombocytopenic purpura.

Related Experiment Videos

[Therapeutic cytapheresis in hairy cell leukemia and chronic myelocytic leukemia]

Related Concept Videos

Related Articles